OrthoPediatrics (NASDAQ:KIDS) Shares Gap Down After Analyst Downgrade

OrthoPediatrics Corp. (NASDAQ:KIDS)’s stock price gapped down before the market opened on Wednesday after Stifel Nicolaus lowered their price target on the stock from $40.00 to $32.00. The stock had previously closed at $22.89, but opened at $22.28. Stifel Nicolaus currently has a buy rating on the stock. OrthoPediatrics shares last traded at $23.69, with a volume of 12,976 shares trading hands.

Other equities research analysts also recently issued research reports about the stock. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Wednesday.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Quarry LP purchased a new stake in OrthoPediatrics in the third quarter worth approximately $25,000. International Assets Investment Management LLC boosted its stake in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after buying an additional 966 shares during the last quarter. R Squared Ltd bought a new stake in shares of OrthoPediatrics in the fourth quarter worth $48,000. KLP Kapitalforvaltning AS purchased a new stake in OrthoPediatrics during the fourth quarter valued at $79,000. Finally, BNP Paribas Financial Markets lifted its holdings in OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares during the period. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Stock Performance

The business has a fifty day simple moving average of $24.45 and a two-hundred day simple moving average of $25.93. The company has a market cap of $608.06 million, a P/E ratio of -20.41 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The company had revenue of $52.67 million for the quarter, compared to the consensus estimate of $51.16 million. During the same quarter last year, the firm posted ($0.23) earnings per share. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.